The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab

Oncologist - United States
doi 10.1634/theoncologist.2010-0154
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Breast Cancer: Rank Ligand Inhibition

Breast Care
SurgeryOncology
2010English

RANK Ligand and the Regulation of Skeletal Remodeling

Journal of Clinical Investigation
Medicine
2003English

RANK-ligand (RANKL) Expression in Young Breast Cancer Patients and During Pregnancy

Breast Cancer Research
Cancer ResearchOncology
2015English

A New Paradigm for an Old Story: The Role of Regulatory B Cells in Cancer

Frontiers in Immunology
AllergyImmunology
2012English

Role of ER Palmitoylation in the Inhibition of Human Colon Cancer Cell Proliferation

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2007English

Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2015English

The Role of Identity of an Animated Character in the Story Line

The Academic Research Community publication
2017English

Renin Inhibition in Heart Failure and Diabetes: The Real Story

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: The Evolving Role of Individualized Therapy

Cancer and Metastasis Reviews
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy